CF
NBP

Cantor Fitzgerald’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Cantor Fitzgerald’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-140,100
Closed -$119K – 357
2024
Q4 		$119K Buy
+140,100
New +$156K ﹤0.01% 208

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cantor Fitzgerald's NBP Position: Q1 2025 in Review

Cantor Fitzgerald sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2025, closing a stake of 140,100 shares — an estimated $119K sold.

Cantor Fitzgerald first reported a position in NBP in Q4 2024 and held it in 1 quarter. The position peaked at $119K in Q4 2024. 29 funds tracked by Wall St. Rank hold NBP as of Q1 2025.

  • Cantor Fitzgerald reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 140,100 NovaBridge Biosciences American Depositary Shares shares in Q1 2025, an estimated $119K.
  • Cantor Fitzgerald first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2024 and held it in 1 quarter.
  • Cantor Fitzgerald's NovaBridge Biosciences American Depositary Shares position peaked at $119K in Q4 2024.
  • 29 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2025.

Based on Cantor Fitzgerald's 13F filing for Q1 2025, filed 15 May 2025.